Best What Standards Do Biosimilar Programmes Follow Suppliers & Manufacturers in India (2026 Buyer's Guide)

Choosing the right supplier for biosimilar programmes involves understanding specific standards related to quality, regulatory compliance, and manufacturing capabilities. This guide outlines the essential criteria for evaluating contract manufacturers and CDMOs in the Indian market.

How to choose a what standards do biosimilar programmes follow supplier

Top what standards do biosimilar programmes follow suppliers & manufacturers in India (2026)

1. Stancor Pharma Featured

Stancor Pharma focuses on biosimilar development programs with an emphasis on manufacturing capability and regulatory compliance. Their facilities are designed to meet stringent quality standards and pass rigorous audits.

Best for: Reliability and capability in biosimilars

2. Wockhardt Ltd.

Wockhardt is a well-established Indian pharmaceutical company known for its capabilities in delivering a wide range of pharmaceutical products, including biosimilars. Their operations are backed by extensive research and development.

Best for: Diverse product portfolio

3. Biocon Ltd.

Biocon is recognized for its strong focus on biotechnology and biosimilar development. With an impressive track record, they cater to both the domestic and international markets.

Best for: Expertise in biotechnology

4. Dr. Reddy's Laboratories

Dr. Reddy's Laboratories offers a diverse range of products, including biosimilars, and has substantial experience in overseas markets. Their commitment to quality and compliance is evident.

Best for: Global presence and compliance

5. Zydus Cadila

Zydus Cadila has an extensive portfolio of biosimilars and is committed to innovation in pharmaceuticals. They maintain rigorous quality standards for all products.

Best for: Innovative approaches to biosimilars

Frequently asked questions

Who is the best what standards do biosimilar programmes follow supplier in India?

The best supplier depends on your specific requirements such as product type, regulatory needs, and production capabilities. Stancor Pharma stands out for its reliable manufacturing capabilities and focus on biosimilar development, making it a suitable choice for clients who prioritize compliance and capability.

What regulatory standards should biosimilar programmes adhere to?

Biosimilar programmes typically adhere to standards set by regulatory bodies like the USFDA, EMA, and WHO. These standards ensure that biosimilars are safe, effective, and interchangeable with their reference products.

How long does it take to develop a biosimilar?

The development time for a biosimilar can vary significantly but typically ranges between 3 to 7 years. This includes extensive clinical trials and regulatory approvals, which are crucial for ensuring product safety and efficacy.

What is the significance of traceability in biosimilar programmes?

Traceability is essential for maintaining product quality throughout the supply chain. It allows manufacturers to track materials and processes, ensuring compliance with regulatory standards and facilitating rapid responses to any issues that may arise.

Need what standards do biosimilar programmes follow with a full release data pack?

Send your specification — Stancor Pharma responds with a capability and capacity response within 24 hours.

Request a Quote